Key Financial Data Of Group

COSMOS Pharmaceutical Corporation - Filing #7588261

Concept As at
2022-08-31
2022-06-01 to
2022-08-31
2021-06-01 to
2022-05-31
As at
2022-05-31
As at
2021-08-31
2021-06-01 to
2021-08-31
Key financial data of group
Business results of group
Net sales
206,122,000,000 JPY
755,414,000,000 JPY
189,409,000,000 JPY
Ordinary profit (loss)
9,626,000,000 JPY
32,861,000,000 JPY
9,301,000,000 JPY
Profit (loss) attributable to owners of parent
6,481,000,000 JPY
23,155,000,000 JPY
6,243,000,000 JPY
Comprehensive income
6,483,000,000 JPY
23,198,000,000 JPY
6,247,000,000 JPY
Net assets
195,406,000,000 JPY
190,507,000,000 JPY
175,142,000,000 JPY
Total assets
373,301,000,000 JPY
363,052,000,000 JPY
343,640,000,000 JPY
Basic earnings (loss) per share
163.68
584.76
157.68
Diluted earnings per share
Equity-to-asset ratio
0.523 xbrli:pure
0.525 xbrli:pure
0.510 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.